The benefits of GLP-1 RAs were more pronounced in elderly patients, individuals of White or Asian descent, those diagnosed with atherosclerotic cardiovascular disease (ASCVD), and patients with poor glycemic control. Here, GLP1R is linked to atherosclerosis.